Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)
Download: Excel (XLSX), Comma-separated (CSV)
Cell line | Drug name | Experimental replicate | Timepoint | Curve type (GR values) | Curve type (relative cell counts) | Experiment name | Number of concentrations | Cell doublings (DMSO control) | GR50 | GRmax | GR_AOC | GEC50 | GRinf | Hill slope (GR values) | R-squared sigmoid fit (GR values) | P-value sigmoid fit (GR values) | R-squared flat fit (GR values) | IC50 | Emax | AUC | EC50 | Einf | Hill slope (relative cell counts) | R-squared sigmoid fit (relative cell counts) | P-value sigmoid fit (relative cell counts) | R-squared flat fit (relative cell counts) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCC1806 | Torin2 | 3 | 72 | sigmoid | sigmoid | HCC1806 Torin2 0 3 72 | 8 | 3.212 | 0.0678 | -0.0927 | 0.522 | 0.0798 | -0.12 | 1.32 | 0.996 | 6.56e-08 | NA | 0.0486 | 0.079 | 0.492 | 0.0442 | 0.0528 | 1.17 | 0.995 | 1.09e-07 | NA |
HCC1806 | Omipalisib | 3 | 72 | sigmoid | sigmoid | HCC1806 omipalisib 0 3 72 | 8 | 3.217 | 0.147 | -0.221 | 0.437 | 0.71 | -0.707 | 0.559 | 0.981 | 7.41e-06 | NA | 0.0642 | 0.0481 | 0.54 | 0.0538 | 0.0749 | 0.919 | 0.979 | 9.93e-06 | NA |
HCC1806 | Alpelisib | 3 | 72 | flat | flat | HCC1806 alpelisib 0 3 72 | 8 | 3.224 | Inf | 0.93 | 0.0502 | 0.0 | 0.93 | 0.01 | -0.335 | 1.0 | 0.948 | Inf | 0.891 | 0.921 | 0.0 | 0.891 | 0.01 | -0.351 | 1.0 | 0.919 |
HCC1806 | Pictilisib | 3 | 72 | sigmoid | sigmoid | HCC1806 pictilisib 0 3 72 | 8 | 3.234 | 14.1 | 0.818 | 0.0423 | 52.2 | -0.98 | 0.831 | 0.814 | 0.00649 | NA | 11.3 | 0.734 | 0.935 | 11.3 | 0.0 | 0.849 | 0.773 | 0.0116 | NA |
HCC1806 | Everolimus | 3 | 72 | sigmoid | sigmoid | HCC1806 everolimus 0 3 72 | 8 | 3.239 | Inf | 0.813 | 0.159 | 0.000271 | 0.812 | 0.356 | 0.879 | 0.00175 | NA | Inf | 0.727 | 0.765 | 0.00022 | 0.729 | 0.377 | 0.879 | 0.00177 | NA |
HCC1806 | WYE-125132 | 3 | 72 | sigmoid | sigmoid | HCC1806 WYE-132 0 3 72 | 8 | 3.242 | Inf | 0.531 | 0.255 | 0.0458 | 0.517 | 0.885 | 0.997 | 3.48e-08 | NA | 0.226 | 0.42 | 0.663 | 0.0335 | 0.402 | 0.855 | 0.996 | 8.79e-08 | NA |
HCC1806 | Sirolimus | 3 | 72 | sigmoid | sigmoid | HCC1806 rapamycin 0 3 72 | 8 | 3.249 | 0.223 | 0.805 | 0.162 | 0.000183 | 0.746 | 0.1 | 0.663 | 0.0382 | NA | 1.05 | 0.717 | 0.76 | 1e-05 | 0.657 | 0.1 | 0.68 | 0.0328 | NA |